Showing results (1301-1310 of 1,825) with videos related to
Sort By:
Pageof 183
Bone Marrow Transplantation|February 8, 2019
The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapiesJakob R Passweg, Helen Baldomero, Grzegorz W Basak, et al.Oncogene|March 1, 2005
Microsatellite instability of selective target genes in HNPCC-associated colon adenomasStefan M Woerner, Matthias Kloor, Annegret Mueller, et al.Leukemia Research|April 23, 2010
Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemiaTim Luetkens, Phillipe Schafhausen, Frederike Uhlich, et al.Ambio|November 25, 2021
Monitoring a changing Arctic: Recent advancements in the study of sea ice microbial communitiesKarley Campbell, Ilkka Matero, Christopher Bellas, et al.International Journal of Oncology|March 16, 2022
Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patientsMaria-Luisa Schubert, Carolina Berger, Alexander Kunz, et al.Bone Marrow Transplantation|May 10, 2023
Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia-a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)Giuliano Filippini Velázquez, Myriam Labopin, Johanna Tischer, et al.Leukemia & Lymphoma|October 12, 2020
Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMTThomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.Bone Marrow Transplantation|December 13, 2023
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotypeXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.International Journal of Cancer|December 4, 2010
Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcomaNicolaus Friedrichs, Marcel Trautmann, Elmar Endl, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2013
CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignanciesEvgeny Klyuchnikov, Jean El-Cheikh, Andreas Sputtek, et al.Pageof 183